Literature DB >> 26529282

HIV-1 Genetic Diversity and Transmitted Drug Resistance in Antiretroviral Treatment-Naive Individuals from Amapá State, Northern Brazil.

Lindomar Dos Anjos Silva1, Flavia Divino2, Márlisson Octávio da Silva Rêgo1, Ivina Geselle Lima Lopes1, Cláudia Maria Nóbrega Costa1, Francis Christian da Silva Pereira1, Ivano de Filippis3, Gonzalo Bello2.   

Abstract

The pattern of HIV-1 subtype distribution and prevalence of transmitted drug resistance mutations (TDRM) is heterogeneous across different Brazilian regions. Little information is available about the molecular epidemiologic profile in Northern Brazil. HIV-1 protease (PR) and reverse transcriptase (RT) sequences were obtained from 97 drug-naive HIV-1-infected individuals from Amapá, one of the most isolated Northern Brazilian states, for subtype determination and analysis of drug resistance mutations. The most prevalent HIV-1 clade observed in Amapá was subtype B (74%), followed by subtype F1 (14%), BF1 recombinants (8%), subtype C (1%), CRF31_BC (1%), and CRF02_AG (1%). Only one TDRM (K103N) was detected in a single patient from our study population. This study reveals that the HIV-1 epidemic in Amapá is characterized by a high level of genetic diversity comparable to that observed in major Brazilian cities, but a much lower rate of TDRM (1%).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26529282     DOI: 10.1089/AID.2015.0280

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  High Prevalence and Onward Transmission of Non-Pandemic HIV-1 Subtype B Clades in Northern and Northeastern Brazilian Regions.

Authors:  Flavia Divino; Andre de Lima Guerra Corado; Felipe Gomes Naveca; Mariane M A Stefani; Gonzalo Bello
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

2.  HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil.

Authors:  André de Lima Guerra Corado; Gonzalo Bello; Renato Augusto Carvalho Leão; Fabiana Granja; Felipe Gomes Naveca
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

Review 3.  Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?

Authors:  Adele S Benzaken; Gerson F M Pereira; Lendel Costa; Amilcar Tanuri; André F Santos; Marcelo A Soares
Journal:  AIDS Res Ther       Date:  2019-08-14       Impact factor: 2.250

4.  Homogenous HIV-1 subtype B from the Brazilian Amazon with infrequent diverse BF1 recombinants, subtypes F1 and C among blood donors.

Authors:  Myuki Alfaia Esashika Crispim; Mônica Nogueira da Guarda Reis; Claudia Abrahim; Dagmar Kiesslich; Nelson Fraiji; Gonzalo Bello; Mariane Martins Araújo Stefani
Journal:  PLoS One       Date:  2019-09-09       Impact factor: 3.240

5.  Characterization of HIV-1 genetic diversity and antiretroviral resistance in the state of Maranhão, Northeast Brazil.

Authors:  Élcio Leal; Claudia Regina Arrais; Marta Barreiros; Jessyca Kalynne Farias Rodrigues; Nilviane Pires Silva Sousa; Daniel Duarte Costa; Francisco Dimitre Rodrigo Pereira Santos; Antonio Dantas Silva; Antonia Iracilda E Silva Viana; Allan Kardec Barros; Kledoaldo Lima
Journal:  PLoS One       Date:  2020-03-27       Impact factor: 3.240

Review 6.  HIV-1 genetic diversity and drug resistance mutations in the northern Brazilian region.

Authors:  Myuki Alfaia Esashika Crispim; Monica Nogueira da Guarda Reis; Mariane Martins de Araujo Stefani
Journal:  Braz J Infect Dis       Date:  2021-07-13       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.